Drugs

Anti-inflammatories could make back pain worse

New high for medicinal cannabis prescriber numbers

Vax less effective with common immune drugs

NSAIDs blunt clodronate fracture benefits

The upside to sulfasalazine’s covid risk

Drug approvals ‘rushed, based on limited data’

Growing threat of cardiomyopathy in ice users

Access concerns for ‘game-changing’ covid therapy
